Latest From AmerisourceBergen Corp.
Expert witness "battle plan," requests for summary judgment, and squabble over DEA drug distribution data offer preview of the first US bellwether trial against opioid manufacturers, distributors and pharmacies.
The head of the UK’s health technology assessment body NICE is stepping down, while the country’s medicines agency, the MHRA, will have an interim chief in the run-up to the UK’s planned Brexit from the European Union on 31 October.
HHS Inspector General paints a more positive picture of FDA’s efforts to bring high-volume compounding into better regulatory control than the agency’s own statements might suggest. That could mean the initiative is able to recede a bit from the top-priority status it has had at the agency for almost a decade.
- Therapeutic Areas
- AmeriSource Health Corp.
- North America
- Parent & Subsidiaries
- Alco Health Distribution Corp.
- Archer Drug Co.
- Bellco Health Corp.
- Bergen Brunswig Corp.
- Bridge Medical Inc.
- LS DuBois Son & Co.
- Michiana Merchandising Systems Inc.
- Mississippi Drug Co. Inc.
- Walker Drug Co.
- Senior Management
Steven H Collis, Chmn., Pres. & CEO
Tim Guttman, CFO
John Chou, Chief Legal & Business Officer
- Contact Info
Phone: (610) 727-7000
P.O. Box 959 Valley Forge, PA 19482
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.